BLOOMAGE BIOTECHNOLOGY CORPORATION revenue breakdown overview

BLOOMAGE BIOTECHNOLOGY CORPORATION revenue for the last year amounted to 5.37 B CNY, the most of which — 2.57 B CNY — came from its highest performing source at the moment, Skin Science Innovation and Transformation, the year earlier bringing 3.76 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought BLOOMAGE BIOTECHNOLOGY CORPORATION 6.65 B CNY, and the year before that — 7.56 B CNY.